In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

Código QR

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

The Antimicrobial Testing Leadership and Surveillance (ATLAS) global surveillance program collected clinical isolates of Enterobacterales (n = 8416) and Pseudomonas aeruginosa (n = 2521) from 41 medical centers in 10 Latin American countries from 2017 to 2019. In vitro activities of ceftazidime-avib...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	James A. Karlowsky, Krystyna M. Kazmierczak, Maria Lavínea Novis de Figueiredo Valente, Elkin Lemos Luengas, Monique Baudrit, Alvaro Quintana, Paurus Irani, Gregory G. Stone, Daniel F. Sahm
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Ceftazidime-avibactam Latin America Surveillance Gram-negative Enterobacterales Pseudomonas aeruginosa Infectious and parasitic diseases RC109-216 Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/0a60f6b6ac304f39b06d01229151dcd9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
por: Wei Yu, et al.
Publicado: (2021)

Analyses of a Ceftazidime-Avibactam-Resistant <italic toggle="yes">Citrobacter freundii</italic> Isolate Carrying <italic toggle="yes">bla</italic><sub>KPC-2</sub> Reveals a Heterogenous Population and Reversible Genotype
por: Mariana Castanheira, et al.
Publicado: (2018)

A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Strain Harboring <italic toggle="yes">bla</italic><sub>KPC-14</sub> Isolated in New York City
por: Siqiang Niu, et al.
Publicado: (2020)

<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
por: Melissa D. Barnes, et al.
Publicado: (2017)

Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
por: Helio S. Sader, et al.
Publicado: (2021)

Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> subsp. <i>pneumoniae</i> Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
por: Carla Fontana, et al.
Publicado: (2021)

Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime-avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in a critically ill patient
por: Paolo Gaibani, et al.
Publicado: (2021)

Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Acute Infection
por: Pavel P. Khil, et al.
Publicado: (2019)

In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing <i>Klebsiella pneumoniae</i>: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
por: Snehal Palwe, et al.
Publicado: (2021)

The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China
por: Dongna Zou, et al.
Publicado: (2021)

OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
por: Christopher Fröhlich, et al.
Publicado: (2019)

Treatment of UTIs Due to <i>Klebsiella pneumoniae</i> Carbapenemase-Producers: How to Use New Antibiotic Drugs? A Narrative Review
por: Caroline Chapelle, et al.
Publicado: (2021)

Struggle To Survive: the Choir of Target Alteration, Hydrolyzing Enzyme, and Plasmid Expression as a Novel Aztreonam-Avibactam Resistance Mechanism
por: Ke Ma, et al.
Publicado: (2020)

Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
por: Laura Martínez-García, et al.
Publicado: (2018)

<italic toggle="yes">Enterobacterales</italic> Infection after Intestinal Dominance in Hospitalized Patients
por: Krishna Rao, et al.
Publicado: (2020)

Differences in antimicrobial susceptibility testing complicating management of IMP carbapenemase-producing Enterobacterales infection
por: C. Hickey, et al.
Publicado: (2021)

Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections
por: Helen L. Zhang, et al.
Publicado: (2021)

Rapid Detection of blaKPC, blaNDM, blaOXA-48-like and blaIMP Carbapenemases in Enterobacterales Using Recombinase Polymerase Amplification Combined With Lateral Flow Strip
por: Fang Wang, et al.
Publicado: (2021)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
por: Chun-Hsiang Chiu, et al.
Publicado: (2020)

Costo-efectividad de ceftazidima/avibactam versus colistin + meropenem en el tratamiento de infecciones por enterobacterias resistentes a carbapenémicos en Chile
por: Gutiérrez A.,Magda, et al.
Publicado: (2021)

Multiple Plasmid Vectors Mediate the Spread of <italic toggle="yes">fosA3</italic> in Extended-Spectrum-β-Lactamase-Producing <italic toggle="yes">Enterobacterales</italic> Isolates from Retail Vegetables in China
por: Luchao Lv, et al.
Publicado: (2020)

Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt
por: Ragaey A. Eid, et al.
Publicado: (2021)

Epidemiology of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacterales in the Greater Mekong Subregion: A Systematic-Review and Meta-Analysis of Risk Factors Associated With Extended-Spectrum Beta-Lactamase and Carbapenemase Isolation
por: Shweta R. Singh, et al.
Publicado: (2021)

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Anna Giammanco, et al.
Publicado: (2017)

Early OXA-48-Producing <italic toggle="yes">Enterobacterales</italic> Isolates Recovered in a Spanish Hospital Reveal a Complex Introduction Dominated by Sequence Type 11 (ST11) and ST405 <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Clones
por: Desirèe Gijón, et al.
Publicado: (2020)

Caracterización de bacilos gramnegativos multi-resistentes, aislados en pacientes hospitalizados en instituciones de salud de Barranquilla (Colombia)
por: Guerra-Sarmiento,Marlene, et al.
Publicado: (2021)

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam
por: Majed F. Alghoribi, et al.
Publicado: (2021)

Actividad antibacteriana de la clara de huevo de la tortuga marina Lepidochelys olivacea
por: López-Hurtado,Marcela, et al.
Publicado: (2010)

Vigilancia de susceptibilidad de cocáceas grampositivas a betalactámicos, glicopéptidos y otros antimicrobianos
por: Giglio M,María Soledad, et al.
Publicado: (1999)

Tropical Atlantic marine macroalgae with bioactivity against virulent and antibiotic resistant Vibrio
por: Silva,Giselle Cristina, et al.
Publicado: (2013)

Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients’ Central Venous Catheters
por: Fangning Liu, et al.
Publicado: (2018)

Enhanced Antibacterial Activity of Se Nanoparticles Upon Coating with Recombinant Spider Silk Protein eADF4(κ16)
por: Huang T, et al.
Publicado: (2020)

Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
por: Fangzhou Wang, et al.
Publicado: (2021)

Cambio en la microbiología de los abscesos pancreáticos en el Hospital Regional de Temuco: Serie de casos
por: LOSADA M,HÉCTOR, et al.
Publicado: (2006)

Comparación de los criterios de Nugent y Spiegel para el diagnóstico de vaginosis bacteriana y análisis de los resultados discordantes por el método de Ison y Hay
por: MARTÍNEZ,MARÍA ANGÉLICA, et al.
Publicado: (2011)

Red de vigilancia de resistencia antimicrobiana PRONARES: Informe primer semestre 2001
por: Trucco A.,Olivia, et al.
Publicado: (2002)

Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality
por: Mar de Pablo-Miró, et al.
Publicado: (2021)

Dual delivery of active antibactericidal agents and bone morphogenetic protein at sustainable high concentrations using biodegradable sheath-core-structured drug-eluting nanofibers
por: Hsu YH, et al.
Publicado: (2016)

Evaluación de la Actividad Antimicrobiana de Extractos de Propóleos de la Huasteca Potosina (México)
por: Carrillo,María L, et al.
Publicado: (2011)

Neumonías por gérmenes Gram negatives
por: Donoso,J. M, et al.
Publicado: (1976)